Skip to main content

Healthpeak Properties, Inc. (DOC) Stock Analysis

SellHigh Confidence

Real Estate · REIT - Healthcare Facilities

Sell if holding. Analyst target reached at $19.30 — A.R:R is negative (-0.3) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: San Francisco (59.0%).

Healthpeak Properties is a healthcare REIT with 689 properties across outpatient medical (507), lab (145), and senior housing (34) segments in the U.S. Revenue is earned through multi-tenant leases; HCA Healthcare accounts for 15% of outpatient medical segment revenues and 7% of... Read more

$19.30+0.6% A.UpsideScore 5.1/10#9 of 13 REIT - Healthcare Facilities
QualityF-score8 / 9FCF yield8.26%
IncomeYield6.26%(5y avg 5.54%)Payout381.26%
Stop $18.06Target $19.41(resistance)A.R:R -0.3:1
Analyst target$20.61+6.8%18 analysts
$19.41our TP
$19.30price
$20.61mean
$17
$29

Sell if holding. Analyst target reached at $19.30 — A.R:R is negative (-0.3) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: San Francisco (59.0%). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.1/10, high confidence.

Passes 6/8 gates (positive momentum, clean insider activity, no SEC red flags, earnings proximity 65d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.

Recent Developments — Healthpeak Properties, Inc.

Generated 2026-05-20T21:06:21Z.

Thesis

Rewards
No bull case signals
Risks
Concentration risk — Geographic: San Francisco (59.0%)
Analyst target reached - limited upside remaining
Near 52-week high (3.1% away)

Key Metrics

P/E (TTM)60.9
P/E (Fwd)144.4
Mkt Cap$13.4B
EV/EBITDA15.7
Profit Mgn7.7%
ROE2.8%
Rev Growth7.1%
Beta0.98
Dividend6.26%
Rating analysts24

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C1.67bearish
IV40%normal

Concentration Risks(10-K Item 1A)

  • HIGHGeographicSan Francisco59%
    10-K Item 1: 'including San Francisco, California (59%), Boston, Massachusetts (22%), and San Diego, California (17%) (based on total square feet)'
  • LOWTenantHCA Healthcare7.0%
    10-K Item 1: 'HCA Healthcare, Inc. (HCA)| | 15 | %| | 7 | %'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

10 dimensions · all in-band

GatesA.R:R -0.3=NEGATIVEMomentum 4.7<5.5 (soft — BUY_NOW allowed but watch)Momentum 4.7>=4.5Insider activity: OKNo SEC red flagsEARNINGS PROXIMITY 65d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Moderate
RSI
84 · Overbought
20D MA 50D MA 200D MAGOLDEN CROSSSupport $15.62Resistance $19.81

Price Targets

$18
$19
A.Upside+0.6%
A.R:R-0.3:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! Target reached (-3.9% upside)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-07-23 (65d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is DOC stock a buy right now?

Sell if holding. Analyst target reached at $19.30 — A.R:R is negative (-0.3) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: San Francisco (59.0%). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $18.06. Score 5.1/10, high confidence.

What is the DOC stock price target?

Take-profit target: $19.41 (+0.6% upside). Prior stop was $18.06. Stop-loss: $18.06.

What are the risks of investing in DOC?

Concentration risk — Geographic: San Francisco (59.0%); Analyst target reached - limited upside remaining; Near 52-week high (3.1% away).

Is DOC overvalued or undervalued?

Healthpeak Properties, Inc. trades at a P/E of 60.9 (forward 144.4). TrendMatrix value score: 4.8/10. Verdict: Sell.

What do analysts say about DOC?

24 analysts cover DOC with a consensus score of 3.7/5. Average price target: $21.

What does Healthpeak Properties, Inc. do?Healthpeak Properties is a healthcare REIT with 689 properties across outpatient medical (507), lab (145), and senior...

Healthpeak Properties is a healthcare REIT with 689 properties across outpatient medical (507), lab (145), and senior housing (34) segments in the U.S. Revenue is earned through multi-tenant leases; HCA Healthcare accounts for 15% of outpatient medical segment revenues and 7% of total revenues. Lab properties are heavily concentrated in San Francisco (59%), Boston (22%), and San Diego (17%).

Related stocks: OHI (Omega Healthcare Investors, Inc) · SBRA (Sabra Health Care REIT, Inc.) · MPT (Medical Properties Trust, Inc.) · AHR (American Healthcare REIT, Inc.) · VTR (Ventas, Inc.)